TaeWeon Lee

1.2k total citations
20 papers, 940 citations indexed

About

TaeWeon Lee is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, TaeWeon Lee has authored 20 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Oncology. Recurrent topics in TaeWeon Lee's work include Cardiac Fibrosis and Remodeling (5 papers), Signaling Pathways in Disease (4 papers) and Peptidase Inhibition and Analysis (4 papers). TaeWeon Lee is often cited by papers focused on Cardiac Fibrosis and Remodeling (5 papers), Signaling Pathways in Disease (4 papers) and Peptidase Inhibition and Analysis (4 papers). TaeWeon Lee collaborates with scholars based in United States, Canada and Germany. TaeWeon Lee's co-authors include Jiwen Liu, Ralph A. DeFronzo, Hui Tian, Nien‐Jung Chen, Colin McKerlie, Wen‐Jye Lin, Hélène Baribault, Christine Mirtsos, Wen-Chen Yeh and Yong‐Chen Lu and has published in prestigious journals such as Nature, Diabetes and Journal of Medicinal Chemistry.

In The Last Decade

TaeWeon Lee

20 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
TaeWeon Lee United States	13	388	300	239	187	123	20	940
Sam Chun United States	7	444 1.1×	365 1.2×	201 0.8×	338 1.8×	132 1.1×	9	1.2k
Tadao Iwasaki Japan	18	298 0.8×	307 1.0×	177 0.7×	136 0.7×	89 0.7×	31	822
Zouher Majd France	15	864 2.2×	354 1.2×	256 1.1×	192 1.0×	231 1.9×	24	1.5k
Kumaravelu Jagavelu India	20	620 1.6×	183 0.6×	52 0.2×	260 1.4×	150 1.2×	59	1.4k
Mysore P. Ramprasad United States	13	395 1.0×	318 1.1×	130 0.5×	556 3.0×	133 1.1×	18	1.2k
Yujun Xu China	22	445 1.1×	175 0.6×	106 0.4×	385 2.1×	108 0.9×	64	1.3k
Miriam Lee‐Rueckert Finland	22	315 0.8×	420 1.4×	204 0.9×	259 1.4×	83 0.7×	42	996
J Kao United States	12	760 2.0×	115 0.4×	238 1.0×	323 1.7×	177 1.4×	12	1.6k
Cathy Malcontenti‐Wilson Australia	16	250 0.6×	139 0.5×	64 0.3×	70 0.4×	91 0.7×	32	802
Naravat Poungvarin Thailand	18	374 1.0×	369 1.2×	125 0.5×	95 0.5×	84 0.7×	49	919

Countries citing papers authored by TaeWeon Lee

Since Specialization

Citations

This map shows the geographic impact of TaeWeon Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by TaeWeon Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites TaeWeon Lee more than expected).

Fields of papers citing papers by TaeWeon Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by TaeWeon Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by TaeWeon Lee. The network helps show where TaeWeon Lee may publish in the future.

Co-authorship network of co-authors of TaeWeon Lee

This figure shows the co-authorship network connecting the top 25 collaborators of TaeWeon Lee. A scholar is included among the top collaborators of TaeWeon Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with TaeWeon Lee. TaeWeon Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gotts, Jeffrey E., Mazharul Maishan, Lauren Chun, et al.. (2021). Delayed angiopoietin‐2 blockade reduces influenza‐induced lung injury and improves survival in mice. Physiological Reports. 9(21). e15081–e15081. 5 indexed citations

Lobb, David C., Heather Doviak, Gregory L. Brower, et al.. (2020). Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post–Myocardial Infarction Remodeling. Journal of Pharmacology and Experimental Therapeutics. 375(2). 296–307. 8 indexed citations

Lee, TaeWeon, et al.. (2019). Incidentalomas of the prostate detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. Canadian Urological Association Journal. 14(5). E180–E184. 9 indexed citations

Lee, TaeWeon, Connor M. Forbes, Martin Gleave, et al.. (2019). Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculator. World Journal of Urology. 38(5). 1215–1220. 12 indexed citations

Thorn, Stephanie, Shayne C. Barlow, Attila Fehér, et al.. (2019). Application of Hybrid Matrix Metalloproteinase-Targeted and Dynamic ²⁰¹ Tl Single-Photon Emission Computed Tomography/Computed Tomography Imaging for Evaluation of Early Post-Myocardial Infarction Remodeling. Circulation Cardiovascular Imaging. 12(11). e009055–e009055. 12 indexed citations

Lee, TaeWeon, et al.. (2018). A risk-stratified approach to the management of high-grade T1 bladder cancer. Current Opinion in Urology. 28(6). 563–569. 4 indexed citations

Purcell, Brendan P., Shayne C. Barlow, Heather Doviak, et al.. (2018). Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling. American Journal of Physiology-Heart and Circulatory Physiology. 315(4). H814–H825. 43 indexed citations

Chintalgattu, Vishnu, Shivani Singh, Amy E. Gilbert, et al.. (2018). Utility of Glycosylated TIMP3 molecules: Inhibition of MMPs and TACE to improve cardiac function in rat myocardial infarct model. Pharmacology Research & Perspectives. 6(6). e00442–e00442. 19 indexed citations

Hegde, Sharath S., Mark A. Luttmann, James J. Foley, et al.. (2018). Pharmacological properties of revefenacin (TD‐4208), a novel, nebulized long‐acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues. Pharmacology Research & Perspectives. 6(3). e00400–e00400. 23 indexed citations

10.

Kim, Ji Hyun, Anthony Elias, TaeWeon Lee, Patrice Maurel, & Haesun A. Kim. (2017). Tissue Inhibitor of Metalloproteinase-3 Promotes Schwann Cell Myelination. ASN NEURO. 9(6). 10 indexed citations

11.

Barlow, Shayne C., Heather Doviak, Julia Jacobs, et al.. (2017). Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function. American Journal of Physiology-Heart and Circulatory Physiology. 313(4). H690–H699. 23 indexed citations

12.

Hughes, Adam D., Yan Chen, Sharath S. Hegde, et al.. (2015). Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1′-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and β₂ Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD). Journal of Medicinal Chemistry. 58(6). 2609–2622. 30 indexed citations

13.

Hegde, Sharath S., Adam D. Hughes, Yan Chen, et al.. (2014). Pharmacologic Characterization of GSK-961081 (TD-5959), a First-in-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties. Journal of Pharmacology and Experimental Therapeutics. 351(1). 190–199. 16 indexed citations

14.

Eckhouse, Shaina R., Brendan P. Purcell, Jeremy R. McGarvey, et al.. (2014). Local Hydrogel Release of Recombinant TIMP-3 Attenuates Adverse Left Ventricular Remodeling After Experimental Myocardial Infarction. Science Translational Medicine. 6(223). 223ra21–223ra21. 88 indexed citations

15.

Liu, Jiwen, TaeWeon Lee, & Ralph A. DeFronzo. (2012). Why Do SGLT2 Inhibitors Inhibit Only 30–50% of Renal Glucose Reabsorption in Humans?. Diabetes. 61(9). 2199–2204. 176 indexed citations

16.

Li, An‐Rong, et al.. (2011). Discovery of non-glucoside SGLT2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(8). 2472–2475. 37 indexed citations

17.

Du, Xiaohui, Mike E. Lizarzaburu, Simon Turcotte, et al.. (2011). Optimization of triazoles as novel and potent nonphlorizin SGLT2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(12). 3774–3779. 13 indexed citations

18.

Wang, Yingcai, Xian‐Yun Jiao, Frank Kayser, et al.. (2009). The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 20(2). 493–498. 83 indexed citations

19.

Lee, TaeWeon, Ralf Schwandner, Gayathri Swaminath, et al.. (2008). Identification and Functional Characterization of Allosteric Agonists for the G Protein-Coupled Receptor FFA2. Molecular Pharmacology. 74(6). 1599–1609. 126 indexed citations

20.

Chen, Nien‐Jung, Christine Mirtsos, Yong‐Chen Lu, et al.. (2007). C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature. 446(7132). 203–207. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact